AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇨🇮
ATEZOLIZUMAB in Côte d'Ivoire
3 products registered with AIRP — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| TECENTRIQ 1200MG/20 ML CONCENTRE POUR SOLUTION A DILUER POUR PERFUSION FLACON DE 20ML | E-2022-0026 | F. HOFFMANN-LA ROCHE LTD | active | 25 May 2027 |
| TECENTRIQ 840MG/14 ML CONCENTRE POUR SOLUTION A DILUER POUR PERFUSION FLACON DE 14ML | E-2022-0025 | F. HOFFMANN-LA ROCHE LTD | active | 25 May 2027 |
| TECENTRIQ SC 1875 MG/ 15 ML SOLUTION INJECTABLE EN SOUS-CUTANEE, FLACON DE 1 | MD/2O0724/0096 | LABORATOIRES F. HOFFMANN-LA ROCHE LTD | active | — |
ATEZOLIZUMAB — AIRP Registration Details
AIRP (Côte d'Ivoire) has 3 registered products containing ATEZOLIZUMAB, of which 3 are currently active. Data is sourced directly from the official AIRP drug register and refreshed daily.
Track ATEZOLIZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.